Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A Predictive Modelling Framework for COVID-19 Transmission to Inform the Management of Mass Events

View ORCID ProfileClaire Donnat, View ORCID ProfileFreddy Bunbury, Jack Kreindler, Filippos T. Filippidis, Austen El-Osta, Tõnu Esko, Matthew Harris
doi: https://doi.org/10.1101/2021.05.13.21256857
Claire Donnat
1Department of Statistics, University of Chicago, Chicago, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Claire Donnat
  • For correspondence: cdonnat@uchicago.edu
Freddy Bunbury
2Department of Plant Biology, Carnegie Institution for Science, Stanford, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Freddy Bunbury
Jack Kreindler
3School of Public Health, Imperial College, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Filippos T. Filippidis
3School of Public Health, Imperial College, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Austen El-Osta
3School of Public Health, Imperial College, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tõnu Esko
6Institute of Genomics, University of Tartu, Tartu, Estonia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Harris
3School of Public Health, Imperial College, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Modelling COVID-19 transmission at live events and public gatherings is essential to evaluate and control the probability of subsequent outbreaks. Model estimates can be used to inform event organizers about the possibility of super-spreading and the predicted efficacy of safety protocols, as well as to communicate to participants their personalised risk so that they may choose whether to attend. Yet, despite the fast-growing body of literature on COVID transmission dynamics, current risk models either neglect contextual information on vaccination rates or disease prevalence or do not attempt to quantitatively model transmission, thus limiting their potential to provide insightful estimates. This paper attempts to bridge this gap by providing informative risk metrics for live public events, along with a measure of their associated uncertainty. Starting with a thorough review of the literature and building upon existing models, our approach ties together three main components: (a) reliable modelling of the number of infectious cases at the time of the event, (b) evaluation of the efficiency of pre-event screening and risk mitigation protocols, and (c) modelling the transmission dynamics during the event. We demonstrate how uncertainty in the input parameters can be included in the model using Monte Carlo simulations. We discuss the underlying assumptions and limitations of our approach and implications for policy around live events management.

Competing Interest Statement

JK is a co-founder and Medical Director at Certific.

Funding Statement

The work of TE has been supported by the Estonian Research Council Grant PRG1291. MH and AEL are supported in part by the NW London NIHR Applied Research Collaboration. Imperial College London is grateful for support from the NW London NIHR Applied Research Collaboration and the Imperial NIHR Biomedical Research Centre. JK is currently Director of Health Optimisation at the Center for Health and Human Performance (London, UK), as well the co-founder and Medical Director of CERTIFIC.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

NA

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • cdonnat{at}uchicago.edu

  • fbunbury{at}carnegiescience.edu

  • j.kreindler{at}imperial.ac.uk

  • f.filippidis{at}imperial.ac.uk

  • a.el-osta{at}imperial.ac.uk

  • tonu.esko{at}ut.ee

  • m.harris{at}imperial.ac.uk

  • ↵4 The IFR have been taken from the following data source: https://github.com/mbevand/covid19-age-stratified-ifr

  • ↵5 This calculator can be found at the following link: https://www.dhs.gov/science-and-technology/sars-airborne-calculator

  • ↵6 Link to the EPA website:https://www.epa.gov/expobox/exposure-factors-handbook-chapter-6

  • ↵7 Link to the ASHRAE tables: https://ashrae.iwrapper.com/ASHRAE_PREVIEW_ONLY_STANDARDS/STD_62.1_2019

Data Availability

The links to all datasets used in this study are explicitly provided in the paper.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted May 16, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A Predictive Modelling Framework for COVID-19 Transmission to Inform the Management of Mass Events
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A Predictive Modelling Framework for COVID-19 Transmission to Inform the Management of Mass Events
Claire Donnat, Freddy Bunbury, Jack Kreindler, Filippos T. Filippidis, Austen El-Osta, Tõnu Esko, Matthew Harris
medRxiv 2021.05.13.21256857; doi: https://doi.org/10.1101/2021.05.13.21256857
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
A Predictive Modelling Framework for COVID-19 Transmission to Inform the Management of Mass Events
Claire Donnat, Freddy Bunbury, Jack Kreindler, Filippos T. Filippidis, Austen El-Osta, Tõnu Esko, Matthew Harris
medRxiv 2021.05.13.21256857; doi: https://doi.org/10.1101/2021.05.13.21256857

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Health Policy
Subject Areas
All Articles
  • Addiction Medicine (230)
  • Allergy and Immunology (507)
  • Anesthesia (111)
  • Cardiovascular Medicine (1264)
  • Dentistry and Oral Medicine (207)
  • Dermatology (148)
  • Emergency Medicine (283)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (538)
  • Epidemiology (10056)
  • Forensic Medicine (5)
  • Gastroenterology (502)
  • Genetic and Genomic Medicine (2486)
  • Geriatric Medicine (240)
  • Health Economics (482)
  • Health Informatics (1653)
  • Health Policy (757)
  • Health Systems and Quality Improvement (638)
  • Hematology (250)
  • HIV/AIDS (538)
  • Infectious Diseases (except HIV/AIDS) (11896)
  • Intensive Care and Critical Care Medicine (627)
  • Medical Education (255)
  • Medical Ethics (75)
  • Nephrology (269)
  • Neurology (2304)
  • Nursing (140)
  • Nutrition (354)
  • Obstetrics and Gynecology (458)
  • Occupational and Environmental Health (537)
  • Oncology (1259)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (158)
  • Palliative Medicine (50)
  • Pathology (326)
  • Pediatrics (737)
  • Pharmacology and Therapeutics (315)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2295)
  • Public and Global Health (4850)
  • Radiology and Imaging (846)
  • Rehabilitation Medicine and Physical Therapy (493)
  • Respiratory Medicine (657)
  • Rheumatology (289)
  • Sexual and Reproductive Health (241)
  • Sports Medicine (228)
  • Surgery (273)
  • Toxicology (44)
  • Transplantation (131)
  • Urology (100)